Notes - Segment Information, Etc.

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7320752

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
174,185,000 JPY
3,393,447,000 JPY
JPY
7,738,426,000 JPY
1,718,102,000 JPY
7,738,426,000 JPY
2,452,690,000 JPY
2,018,839,000 JPY
180,435,000 JPY
2,001,200,000 JPY
8,660,379,000 JPY
8,660,379,000 JPY
4,459,904,000 JPY
JPY
Other items
Depreciation
32,508,000 JPY
211,076,000 JPY
JPY
411,587,000 JPY
52,332,000 JPY
411,587,000 JPY
115,669,000 JPY
54,730,000 JPY
36,988,000 JPY
106,244,000 JPY
445,752,000 JPY
445,752,000 JPY
247,789,000 JPY
JPY
Increase in property, plant and equipment and intangible assets
8,257,000 JPY
244,480,000 JPY
JPY
493,180,000 JPY
80,240,000 JPY
493,180,000 JPY
160,200,000 JPY
15,795,000 JPY
JPY
55,017,000 JPY
139,381,000 JPY
139,381,000 JPY
68,568,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.